Back
Speaker illustration

Doctor Atsushi Tada

Mayo Clinic, Rochester (United States of America)

Member of:

European Society of Cardiology

Presentations

Primary inflammatory disease in heart failure with preserved ejection fraction

Event: ESC Congress 2024

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Cardiac amyloidosis, sarcoidosis, and inflammation

Access
Like
Thumbnail

Dapagliflozin enhances arterial and venous compliance during exercise in heart failure with preserved ejection fraction

Event: ESC Congress 2024

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Diagnosis and prognosis of HFpEF

Access
Like
Thumbnail

Prognostic value of liver fibrotic markers in patients with heart failure

Event: ESC Congress 2023

Topic: Biomarkers

Session: Emerging evidence for biomarkers in heart failure

Access
Like
Thumbnail

Validation of the HFA-PEFF and the H2FPEF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients:a report from the Japanese multicentre registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic heart failure e-posters

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources